NEW YORK (GenomeWeb News) – Genometry announced today that it has signed a multi-year deal with Janssen Pharmaceutica to generate gene-expression profiles from 250,000 compounds in Janssen's small-molecule screening library using its L1000 Expression profiling system.

The L1000 is designed to produce high-dimensional, gene-expression profiles from crude cell lysates in a 384-well plate format. The technology was developed at the Broad Institute, MIT, and the Dana-Farber Cancer Institute, and exclusively licensed by Genometry for pharmaceutical applications.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.